Table 6.
AMELD score and DRI of recipients of ABO-identical versus -nonidentical liver transplants by recipient blood type, reported as median (interquartile range)
| Recipient–donor ABO match
|
p-value | ||||
|---|---|---|---|---|---|
| Identical | Nonidentical | ||||
| Recipient ABO | O | AMELD | 29 (23–36) | 34 (29–40) | <0.001 |
| LMELD1 | 27 (18–36) | 33 (24–39) | <0.001 | ||
| DRI | 1.49 (1.22–1.79) | 1.48 (1.17–1.81) | 0.47 | ||
| A | AMELD | 29 (24–35) | 19 (14–25) | <0.001 | |
| LMELD1 | 26 (19–35) | 16 (12–21) | <0.001 | ||
| DRI | 1.46 (1.20–1.75) | 1.62 (1.48–1.84) | <0.001 | ||
| B | AMELD | 25 (22–29) | 38 (33–40) | <0.001 | |
| LMELD1 | 21 (16–27) | 35 (30–41) | <0.001 | ||
| DRI | 1.47 (1.20–1.77) | 1.43 (1.18–1.68) | 0.19 | ||
| AB | AMELD | 22 (19–25) | 28 (22–37) | <0.001 | |
| LMELD1 | 19 (15–24) | 29 (19–36) | <0.001 | ||
| DRI | 1.47 (1.22–1.81) | 1.36 (1.19–1.62) | 0.002 | ||
AMELD, allocation Model of End-Stage Liver Disease score; DRI, donor risk index; LMELD, laboratory Model of End-Stage Liver Disease score.
1
Among those without Model of End-Stage Liver Disease exception points.